Benzinga
02 Mar 2026, 17:30 UTC · 35w ago
Elevance Health Stock Sinks After CMS Freezes Medicare Advantage Enrollment
Impact · against what's priced in
Elevance Health faces a severe catalyst as CMS freezes Medicare Advantage enrollment due to persistent regulatory non-compliance. This, combined with revised 2026 earnings guidance ($25.50 vs $26.90 estimate) and a forecast of declining sales, creates a significant downward shift in valuation.
- ELV−0.90
No priced-in read yet
- In context
The enrollment freeze starting March 31, 2026, halts growth in a core segment, while guidance for FY2026 earnings of $25.50 per share misses the $26.90 Wall Street consensus.
Read from the article alone
